Predicted protein targets (top 9)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | OPRM1 | P35372 | 2/20 | 0.59 |
| ▸ | OPRD1 | P41143 | 2/20 | 0.59 |
| ▸ | ERAP1 | Q9NZ08 | 2/20 | 0.59 |
| ▸ | ERAP2 | Q6P179 | 2/20 | 0.59 |
| ▸ | LNPEP | Q9UIQ6 | 1/20 | 0.59 |
| ▸ | NPY1R | P25929 | 1/20 | 0.59 |
| ▸ | NPY2R | P49146 | 1/20 | 0.59 |
| ▸ | NPY4R | P50391 | 1/20 | 0.59 |
| ▸ | IL1RN | P18510 | 1/20 | 0.58 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL29362220 | 0.97 | OPRM1 (0.59) | OPRM1OPRD1ERAP1ERAP2LNPEP | |
| SCHEMBL30567443 | 0.94 | NPY1R (0.62) | ERAP1ERAP2LNPEPNPY1RNPY2R | |
| SCHEMBL30799782 | 0.93 | NPY1R (0.63) | NPY1RNPY2RNPY4R | |
| SCHEMBL22366988 | 0.92 | GHSR (0.57) | OPRM1OPRD1 | |
| SCHEMBL22366987 | 0.92 | GHSR (0.57) | OPRM1OPRD1 | |
| SCHEMBL29577129 | 0.92 | ERAP1 (0.68) | OPRM1OPRD1ERAP1ERAP2LNPEP | |
| SCHEMBL29577668 | 0.92 | ERAP1 (0.68) | OPRM1OPRD1ERAP1ERAP2LNPEP | |
| SCHEMBL30010303 | 0.92 | ERAP1 (0.68) | OPRM1OPRD1ERAP1ERAP2LNPEP | |
| SCHEMBL31483387 | 0.91 | ERAP2 (0.62) | OPRM1OPRD1ERAP1ERAP2LNPEP | |
| SCHEMBL29578349 | 0.91 | OPRM1 (0.67) | OPRM1OPRD1ERAP1ERAP2LNPEP |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-4370150-A1 | OVERCOMING ANTIBODY-INTERFERENCE IN AVIANS | Intervet International B.V. (NL) | 2024-05-22 | — | — | EP | disclosed |
| WO-2023285489-A1 | OVERCOMING ANTIBODY-INTERFERENCE IN AVIANS | INTERVET INTERNATIONAL B.V. (NL) | 2023-01-19 | — | — | WO | disclosed |